Catalyst Wire Dossier Catalyst Wire Dossier

Hearticelgram-AMI

· Pharmicell Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Hearticelgram-AMI, covering 2026-02-09 to 2026-02-09. Get the full timeline:

Most recent: Clinical Trial Update: To Evaluate the Efficacy and Safety of Hearticelgram®-AMI in Patients With Acute Myocardial Infarction. [Phase 3]

See pricing